MRI-guided Radiation Therapy Systems Market to Create Lucrative Opportunities for Emerging Players, Finds Fact.MR

Posted on 2019-08-26 by Mark Hub in Internet & Online // 0 Comments

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR. This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.

In Brief

The Magnetic Resonance Imaging (MRI)-guided radiation therapy systems market was valued at nearly US$ 221 Mn in 2018, and is expected to register 31% y-o-y growth in 2019. The MRI-guided radiation therapy systems industry has been underpinned by the emergence of advanced technologies in healthcare and medical devices industries.
Increasing adoption of radiotherapy in cancer treatment is fuelling demand for MRI-guided radiation therapy systems. The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.
North America remains the leading market for MRI-guided radiation therapy systems, as the percentage of cancer patients treated with radiation therapy in the United States (U.S.) is witnessing a rapid rise.
With a significant rise in the national expenditures for cancer care in the U.S., which is primarily triggered by the alarming rise in cancer prevalence, North America is expected to remain the high-growth market for MRI-guided radiation therapy systems.

Request Free Sample Report Here: https://www.factmr.com/connectus/sample?flag=S&rep_id=2572

MRI-guided Radiation Therapy Systems Market – Competitive Landscape

The technology used in MRI-guided radiation therapy systems is relatively new, and the market is yet at its infancy. Implementing a new technology to introduce an innovative radiation therapy system that is MRI-compatible, without the interference of one component with another, requires extensive R&D and significant capital investments. Manufacturers rely on licensing and patenting their innovative technologies for revenues and sales. Currently, only two companies have a substantial presence in the MRI-guided radiation therapy systems market—Elekta AB and Viewray Technologies, Inc.

Elekta AB

Established in 1972, Elekta AB is headquartered in Stockholm, Sweden. The Swiss company provides radiation therapy equipment and clinical management systems, and it is gaining momentum in the cancer care segment with its Precision Radiation Medicine and other products. The company is adopting strategies to receive FDA approvals for its MRI-guided radiation therapy systems in order to establish a stronger position in North America.

The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America. In 2017, the per capita health expenditure was over US$10,000 in the U.S., recording an increase of nearly 4% over 2016, according to studies. In addition, an alarming rise in the prevalence of cancer in the U.S. will reflect in a significant demand for MRI-guided radiation therapy systems in North America.

According to the study, North America accounted for 45% sales of MRI-guided radiation therapy systems in 2018. Healthcare organizations in the region are investing heavily in tech-driven radiation treatments for cancer. While demand remains robust in developed markets, developing economies are also emerging as attractive markets for MRI-guided radiation therapy systems. Increasing government investments in healthcare infrastructure in the region, are expected to create new opportunities for the players in the MRI-guided radiation therapy systems market.

The study offers comprehensive outlook of the MRI-guided radiation therapy systems market for the period, 2018 to 2028. The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.

Have Any Query?? Ask Our Industry Expert: https://www.factmr.com/connectus/sample?flag=AE&rep_id=2572

About US

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick